PVI
MIST icon

Pura Vida Investments’s Milestone Pharmaceuticals MIST Stock Holding History

Pura Vida Investments’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-371,788
Closed -$1.47M – 135
2022
Q4 		$1.47M Sell
371,788
-224,743
-38% -$1.18M 0.08% 134
2022
Q3 		$5.48M Sell
596,531
-390,880
-40% -$2.96M 0.32% 80
2022
Q2 		$6.07M Hold
987,411
– – 0.35% 78
2022
Q1 		$6.34M Buy
987,411
+55,900
+6% +$349K 0.21% 109
2021
Q4 		$6.1M Buy
931,511
+81,199
+10% +$486K 0.22% 104
2021
Q3 		$4.86M Buy
850,312
+147,767
+21% +$833K 0.15% 149
2021
Q2 		$3.86M Buy
702,545
+234,905
+50% +$1.33M 0.12% 132
2021
Q1 		$2.71M Buy
467,640
+17,640
+4% +$129K 0.08% 146
2020
Q4 		$3.02M Buy
450,000
+350,000
+350% +$2.34M 0.11% 125
2020
Q3 		$732K Buy
+100,000
New +$717K 0.04% 138

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's MIST Position: Q1 2023 in Review

Pura Vida Investments sold out of Milestone Pharmaceuticals (MIST) in Q1 2023, closing a stake of 371,788 shares — an estimated $1.47M sold.

Pura Vida Investments first reported a position in MIST in Q3 2020 and held it in 10 quarters. The position peaked at $6.34M in Q1 2022. 50 funds tracked by Wall St. Rank hold MIST as of Q1 2023.

  • Pura Vida Investments reported no remaining Milestone Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 371,788 Milestone Pharmaceuticals shares in Q1 2023, an estimated $1.47M.
  • Pura Vida Investments first reported a position in Milestone Pharmaceuticals in Q3 2020 and held it in 10 quarters.
  • Pura Vida Investments's Milestone Pharmaceuticals position peaked at $6.34M in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.